Literature DB >> 19828154

Features of intrathecal immunoglobulins in patients with multiple sclerosis.

Franziska Di Pauli1, Viktoria Gredler, Bettina Kuenz, Andreas Lutterotti, Rainer Ehling, Claudia Gneiss, Michael Schocke, Florian Deisenhammer, Markus Reindl, Thomas Berger.   

Abstract

We have analyzed immunoglobulin (Ig) isotypes and IgG subclasses in cerebrospinal fluid (CSF) and serum of patients with multiple sclerosis (MS) and other neurological diseases to determine whether different Ig isotype patterns correlate with clinical or paraclinical findings and CSF B cell populations. Intrathecal IgG1 synthesis was elevated in MS patients. An increased intrathecal IgM production was found in patients with a higher cerebral MRI lesion burden, whereas other clinical and paraclinical parameters were not associated with a specific Ig isotype or subclass profile. Finally, intrathecal IgG production (IgG1 and IgG3) correlated with the presence of mature B cells and plasma blasts.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19828154     DOI: 10.1016/j.jns.2009.09.016

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  7 in total

1.  Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor?

Authors:  Jessica Frau; Luisa Maria Villar; Claudia Sardu; Maria Antonietta Secci; Lucia Schirru; Diana Ferraro; Giancarlo Coghe; Lorena Lorefice; Giuseppe Fenu; Roberta Bedin; Patrizia Sola; Maria Giovanna Marrosu; Eleonora Cocco
Journal:  J Neurol       Date:  2017-12-22       Impact factor: 4.849

2.  High interindividual variability in the CD4/CD8 T cell ratio and natalizumab concentration levels in the cerebrospinal fluid of patients with multiple sclerosis.

Authors:  A Harrer; G Pilz; P Wipfler; K Oppermann; J Sellner; W Hitzl; E Haschke-Becher; S Afazel; T Rispens; D van der Kleij; E Trinka; J Kraus
Journal:  Clin Exp Immunol       Date:  2015-04-27       Impact factor: 4.330

3.  Proteomics comparison of cerebrospinal fluid of relapsing remitting and primary progressive multiple sclerosis.

Authors:  Marcel P Stoop; Vaibhav Singh; Lennard J Dekker; Mark K Titulaer; Christoph Stingl; Peter C Burgers; Peter A E Sillevis Smitt; Rogier Q Hintzen; Theo M Luider
Journal:  PLoS One       Date:  2010-08-27       Impact factor: 3.240

4.  CSF parameters associated with early MRI activity in patients with MS.

Authors:  Ana Klein; Rebecca C Selter; Alexander Hapfelmeier; Achim Berthele; Bertram Müller-Myhsok; Viola Pongratz; Christiane Gasperi; Claus Zimmer; Mark Mühlau; Bernhard Hemmer
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2019-05-30

Review 5.  B cells in central nervous system disease: diversity, locations and pathophysiology.

Authors:  Rajiv W Jain; V Wee Yong
Journal:  Nat Rev Immunol       Date:  2021-12-13       Impact factor: 108.555

6.  Secondary B cell receptor diversification is necessary for T cell mediated neuro-inflammation during experimental autoimmune encephalomyelitis.

Authors:  Georgina Galicia; Bryant Boulianne; Natalia Pikor; Alberto Martin; Jennifer L Gommerman
Journal:  PLoS One       Date:  2013-04-22       Impact factor: 3.240

7.  MK2 and Fas receptor contribute to the severity of CNS demyelination.

Authors:  Silvia M Tietz; Regina Hofmann; Tobias Thomas; Björn Tackenberg; Matthias Gaestel; Martin Berghoff
Journal:  PLoS One       Date:  2014-06-25       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.